Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress

Transfusion and Apheresis Science

Volumn 55, Issue 1, 2016, Pages 35-43

  Maurer Spurej, Elisabeth ^a,b,c   Larsen, Rune ^d   Labrie, Audrey ^b   Heaton, Andrew ^e   Chipperfield, Kate ^f  

^a CANADIAN BLOOD SERVICES   (Canada)

^b LightIntegra Technology Inc   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d University of Copenhagen   (Denmark)

^e HeatonDx Consulting   (United States)

^f BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Donors; Dynamic light scattering; Microparticles; Platelet additive solution; Platelets

Indexed keywords

THROMBOCYTE CONCENTRATE;

APHERESIS; DATA ANALYSIS; DONOR; FLOW CYTOMETRY; GAMMA IRRADIATION; GENERAL HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; NEW YORK; PATHOGEN REDUCTION SYSTEM; PATHOGENESIS; PHYSICAL STRESS; PLASMA; PLATELET-RICH PLASMA CELL; REVIEW; THROMBOCYTE; THROMBOCYTE RICH PLASMA; BLOOD DONOR; BLOOD SAFETY; CYTOLOGY; DISINFECTION; FEMALE; MALE; MEMBRANE MICROPARTICLE; METABOLISM; PROCEDURES; THROMBOCYTOPHERESIS;

BLOOD DONORS; BLOOD PLATELETS; BLOOD SAFETY; CELL-DERIVED MICROPARTICLES; DISINFECTION; FEMALE; HUMANS; MALE; PLATELET-RICH PLASMA; PLATELETPHERESIS;

EID: 84979655778     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.07.010     Document Type: Review

References (38)

1. [1] Simak, J., Gelderman, M.P., Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20 (2006), 1–26.
2. [2] Goubran, H.A., Burnouf, T., Stakiw, J., Seghatchian, J., Platelet microparticle: a sensitive physiological “fine tuning” balancing factor in health and disease. Transfus Apher Sci 52 (2015), 12–18.
3. [3] Burnouf, T., Chou, M.-L., Goubran, H., Cognasse, F., Garaud, O., Seghatchian, J., An overview of the role of microparticles/microvesicles in blood components: are they clinically beneficial or harmful?. Transfus Apher Sci 53 (2015), 137–145.
4. [4] Cognasse, F., Hamzeh-Cognasse, H., Laradi, S., Chou, M.-L., Seghatchian, J., Burnouf, T., et al. The role of microparticles in inflammation and transfusion: a concise review. Transfus Apher Sci 53 (2015), 159–167.
5. [5] Flaumenhaft, R., Formation and fate of platelet microparticles. Blood Cells Mol Dis 36 (2006), 182–187.
6. [6] Keuren, J.F., Magdeleyns, E.J., Govers-Riemslag, J.W., Lindhout, T., Curvers, J., Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 134 (2006), 307–313.
7. [7] Nantakomol, D., Imwong, M., Mas-Oodi, S., Plabplueng, C.D., Isarankura-Na-Ayudhya, C., Prachayasittikul, V., et al. Increase membrane vesiculation in essential hypertension. Lab Med 43 (2012), 6–9.
8. [8] Viera, A.J., Mooberry, M., Key, N.S., Microparticles in cardiovascular disease pathophysiology and outcomes. J Am Soc Hypertens 6 (2012), 243–252.
9. [9] Alijotas-Reig, J., Palacio-Garcia, C., Llurba, E., Vilardell-Tarres, M., Cell-derived microparticles and vascular pregnancy complications: a systematic and comprehensive review. Fertil Steril 99 (2013), 441–449.
10. [10] Maslanka, K., Uhrynowska, M., Lopacz, P., Wrobel, A., Smolenska-Sym, G., Guz, K., et al. Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea. Vox Sang 108 (2015), 27–36.
11. [11] Soop, A., Hallstrom, L., Frostell, C., Wallen, H., Mobarrez, F., Pisetsky, D.S., Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects. Scand J Immunol 78 (2013), 205–213.
12. [12] Tripodi, A., Branchi, A., Chantarangkul, V., Clerici, M., Merati, G., Artoni, A., et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis 31 (2011), 165–172.
13. [13] Chamouard, P., Desprez, D., Hugel, B., Kunzelmann, C., Gidon-Jeangirard, C., Lessard, M., et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci 50 (2005), 574–580.
14. [14] Woei, A.J.F.J., van der Starre, W.E., Tesselaar, M.E., Garcia Rodriguez, P., van Nieuwkoop, C., Bertina, R.M., et al. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections. Thromb Res 133 (2014), 799–803.
15. [15] Woth, G., Tokes-Fuzesi, M., Magyarlaki, T., Kovacs, G.L., Vermes, I., Muhl, D., Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis. Ann Clin Biochem 49 (2012), 554–560.
16. [16] Pisetsky, D., Ullal, A.J., Gauley, J., Ning, T.C., Microparticles as mediators and biomarkers of rheumatic disease. Rheumatology 51 (2012), 1737–1746.
17. [17] Pelletier, F., Garnache-Ottou, F., Angelot, F., Biichlé, S., Vidal, C., Humbert, P., et al. Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis. J Invest Dermatol 131 (2011), 1573–1576.
18. [18] Duarte, D., Taveira-Gomes, T., Sokhatska, O., Palmares, C., Costa, R., Negrao, R., et al. Increased circulating platelet microparticles as a potential biomarker in asthma. Allergy 68 (2013), 1073–1075.
19. [19] Laresche, C., Pelletier, F., Sokhatska, O., Garnache-Ottou, F., Lihoreau, T., Biichlé, S., et al. Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. J Invest Dermatol 134 (2014), 176–182.
20. [20] Johnson, L., Schubert, P., Tan, S., Devine, D.V., Marks, D.C., Extended storage and glucose exhaustion are associated with apoptotic changes in platelets stored in additive solution. Transfusion, 2015, 10.1111/trf.13345 http://dx.doi.org/10.1111/trf.13345.
21. [21] Kriebardis, A., Antonelou, M., Stamoulis, K., Papassideri, I., Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?. Blood Transfus 10:Suppl. 2 (2012), s25–38.
22. [22] Warkentin, T.E., Platelet microparticle generation assay for detection of HIT antibodies: advance, retreat, or too soon to tell?. Thromb Res 133 (2014), 957–958.
23. [23] Hoffmeister, K.M., Felbinger, T.W., Falet, H., Denis, C.V., Bergmeier, W., Mayadas, T.N., et al. The clearance mechanism of chilled blood platelets. Cell 112 (2003), 87–97.
24. [24] Laffont, B., Corduan, A., Rousseau, M., Duchez, A.C., Lee, C.H., Boilard, E., et al. Platelet microparticles reprogram macrophage gene expression and function. Thromb Haemost 115 (2016), 311–323.
25. [25] Phang, M., Lincz, L., Seldon, M., Garg, M.L., Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects. J Nutr Biochem 23 (2012), 1128–1133.
26. [26] Wu, S.Y., Mayneris-Perxachs, J., Lovegrove, J.A., Todd, S., Yaqoob, P., Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype. Am J Clin Nutr 100 (2014), 1232–1243.
27. [27] Sossdorf, M., Otto, G.P., Claus, R.A., Gabriel, H.H., Losche, W., Cell-derived microparticles promote coagulation after moderate exercise. Med Sci Sports Exerc 43 (2011), 1169–1176.
28. [28] Rank, A., Nieuwland, R., Liebhardt, S., Iberer, M., Grutzner, S., Toth, B., et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang 100 (2011), 179–186.
29. [29] Chou, M.L., Lin, L.T., Devos, D., Burnouf, T., Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment. Transfusion 55 (2015), 2433–2444.
30. [30] Labrie, A., Marshall, A., Bedi, H., Maurer-Spurej, E., Characterization of platelet concentrates using dynamic light scattering. Transfus Med Hemother 40 (2013), 93–100.
31. [31] Xu, Y., Nakane, N., Maurer-Spurej, E., Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering. Transfusion 51 (2011), 363–370.
32. [32] Robert, S., Lacroix, R., Poncelet, P., Harhouri, K., Bouriche, T., Judicone, C., et al. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles – brief report. Arterioscler Thromb Vasc Biol 32 (2012), 1054–1058.
33. [33] Strasser, E.F., Happ, S., Weiss, D.R., Pfeiffer, A., Zimmermann, R., Eckstein, R., Microparticle detection in platelet products by three different methods. Transfusion 53 (2013), 156–166.
34. [34] Tobian, A.A., Fuller, A.K., Uglik, K., Tisch, D.J., Borge, P.D., Benjamin, R.J., et al. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME). Transfusion 54 (2014), 1523–1529 quiz 2.
35. [35] Lacroix, R., Robert, S., Poncelet, P., Kasthuri, R.S., Key, N.S., Dignat-George, F., Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 8 (2010), 2571–2574.
36. [36] Orozco, A.F., Lewis, D.E., Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 77 (2010), 502–514.
37. [37] Chandler, W.L., Yeung, W., Tait, J.F., A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 9 (2011), 1216–1224.
38. [38] Ayers, L., Kohler, M., Harrison, P., Sargent, I., Dragovic, R., Schaap, M., et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 127 (2011), 370–377.